ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 317 filers reported holding ROYALTY PHARMA PLC in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $297,936 | +32.8% | 9,692 | +55.6% | 0.00% | – |
| Q1 2023 | $224,396 | -90.1% | 6,228 | -88.9% | 0.00% | -100.0% |
| Q3 2022 | $2,261,000 | +1.0% | 56,268 | +5.7% | 0.00% | 0.0% |
| Q2 2022 | $2,239,000 | +580.5% | 53,249 | +532.4% | 0.00% | – |
| Q1 2022 | $329,000 | -31.5% | 8,420 | -30.1% | 0.00% | -100.0% |
| Q4 2021 | $480,000 | +138.8% | 12,041 | +117.1% | 0.00% | – |
| Q3 2021 | $201,000 | -7.8% | 5,546 | +4.2% | 0.00% | – |
| Q2 2021 | $218,000 | -7.2% | 5,321 | -1.0% | 0.00% | – |
| Q1 2021 | $235,000 | – | 5,376 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $244,378,000 | 79.54% |
| Vantage Consulting Group Inc | 7,862,542 | $284,152,000 | 60.85% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $96,878,000 | 60.36% |
| Indie Asset Partners, LLC | 701,323 | $25,346,000 | 20.53% |
| HARVARD MANAGEMENT CO INC | 7,142,856 | $258,143,000 | 15.13% |
| Bleichroeder LP | 1,115,980 | $40,332,000 | 6.55% |
| Overbrook Management Corp | 785,132 | $28,375,000 | 6.16% |
| Geo Capital Gestora de Recursos Ltd | 194,305 | $7,022,000 | 3.21% |
| Brown University | 621,759 | $22,470,000 | 3.05% |
| Graypoint LLC | 610,584 | $22,067,000 | 2.71% |